10:10 AM EST - Oncolytics Biotech Inc : Announces that the United States Patent and Trademark Office has issued a new patent broadly protecting the Company's proprietary manufacturing process for pelareorep. The newly issued patent covers key aspects of the methods used to manufacture pelareorep and is expected to provide intellectual property protection into 2044. Oncolytics Biotech Inc
shares N.ONCY are trading up $0.06 at $0.91.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=ONCY&qmodStoryID=7877813681862526
